Tackling the mechanisms behind depression

See allHide authors and affiliations

Science  23 Feb 2018:
Vol. 359, Issue 6378, pp. 881-882
DOI: 10.1126/science.359.6378.881-e

The anaesthetic drug ketamine also has a rapid antidepressant effect. Although ketamine is known to block N-methyl-d-aspartate (NMDA) receptors, its exact target—which brain region and which cell groups—has remained elusive. Yang et al. found that neuronal burst firing in a single brain region called the lateral habenula drove robust depressive-like behaviors. These behaviors could be rapidly blocked by local ketamine infusion. Instead of acting on GABAergic neurons as previously suggested, ketamine blocked glutamatergic neurons in the “anti-reward center” lateral habenula to disinhibit downstream dopaminergic and serotonergic neurons. Lateral habenula bursting strongly required the synergistic action of NMDA receptors and voltage-sensitive T-type calcium channels. The latter may therefore be another promising target for the development of new rapid-acting antidepressants.

Nature 10.1038/nature25509 (2018).

Navigate This Article